NEW YORK (GenomeWeb) – AbbVie today announced it is renewing its association with the Structural Genomics Consortium (SGC) for five years with a C$7.5 million (US$5.6 million) cash sponsorship.

The money will be used for open access research to discover new medicines, the firm said in a statement, focusing on chemical tools to explore classes of proteins such as those involved in ion channels, solute carrier channels, and epigenetic regulation.

AbbVie has supported the consortium since 2012.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.